365 related articles for article (PubMed ID: 28978801)
1. Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.
Bhargava P; Fitzgerald KC; Calabresi PA; Mowry EM
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978801
[TBL] [Abstract][Full Text] [Related]
2. High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial.
Kouchaki E; Afarini M; Abolhassani J; Mirhosseini N; Bahmani F; Masoud SA; Asemi Z
J Nutr; 2018 Aug; 148(8):1380-1386. PubMed ID: 29982544
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics: A potential way to know the role of vitamin D on multiple sclerosis.
Luque-Córdoba D; Luque de Castro MD
J Pharm Biomed Anal; 2017 Mar; 136():22-31. PubMed ID: 28063332
[TBL] [Abstract][Full Text] [Related]
4. Correlation between vitamin D and alterations in MRI among patients with multiple sclerosis.
Piędel F; Rocka A; Piwek M; Jasielski PP; Petit V; Rejdak K
Ann Agric Environ Med; 2021 Sep; 28(3):372-377. PubMed ID: 34558256
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolomics in adults with cystic fibrosis during a pulmonary exacerbation: A pilot randomized study of high-dose vitamin D
Alvarez JA; Chong EY; Walker DI; Chandler JD; Michalski ES; Grossmann RE; Uppal K; Li S; Frediani JK; Tirouvanziam R; Tran VT; Tangpricha V; Jones DP; Ziegler TR
Metabolism; 2017 May; 70():31-41. PubMed ID: 28403943
[TBL] [Abstract][Full Text] [Related]
7. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
8. Alterations of host-gut microbiome interactions in multiple sclerosis.
Cantoni C; Lin Q; Dorsett Y; Ghezzi L; Liu Z; Pan Y; Chen K; Han Y; Li Z; Xiao H; Gormley M; Liu Y; Bokoliya S; Panier H; Suther C; Evans E; Deng L; Locca A; Mikesell R; Obert K; Newland P; Wu Y; Salter A; Cross AH; Tarr PI; Lovett-Racke A; Piccio L; Zhou Y
EBioMedicine; 2022 Feb; 76():103798. PubMed ID: 35094961
[TBL] [Abstract][Full Text] [Related]
9. High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial.
Holmøy T; Lindstrøm JC; Eriksen EF; Steffensen LH; Kampman MT
BMC Neurol; 2017 Apr; 17(1):67. PubMed ID: 28376767
[TBL] [Abstract][Full Text] [Related]
10. Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
Cortese M; Riise T; Bjørnevik K; Holmøy T; Kampman MT; Magalhaes S; Pugliatti M; Wolfson C; Myhr KM
Mult Scler; 2015 Dec; 21(14):1856-64. PubMed ID: 25948625
[TBL] [Abstract][Full Text] [Related]
11. An untargeted metabolomics-driven approach based on LC-TOF/MS and LC-MS/MS for the screening of xenobiotics and metabolites of Zhi-Zi-Da-Huang decoction in rat plasma.
Wu H; Li X; Yan X; An L; Luo K; Shao M; Jiang Y; Xie R; Feng F
J Pharm Biomed Anal; 2015 Nov; 115():315-22. PubMed ID: 26275719
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
Kampman MT; Steffensen LH; Mellgren SI; Jørgensen L
Mult Scler; 2012 Aug; 18(8):1144-51. PubMed ID: 22354743
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D
Rolf L; Muris AH; Bol Y; Damoiseaux J; Smolders J; Hupperts R
J Neurol Sci; 2017 Jul; 378():30-35. PubMed ID: 28566173
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Supplementation Reduces Both Oxidative DNA Damage and Insulin Resistance in the Elderly with Metabolic Disorders.
Wenclewska S; Szymczak-Pajor I; Drzewoski J; Bunk M; Śliwińska A
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200560
[TBL] [Abstract][Full Text] [Related]
15. Standard Doses of Cholecalciferol Reduce Glucose and Increase Glutamine in Obesity-Related Hypertension: Results of a Randomized Trial.
Santos C; Carvalho R; Fonseca AM; Castelo Branco M; Alves M; Jarak I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542390
[TBL] [Abstract][Full Text] [Related]
16. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics-based parallel discovery of xenobiotics and induced endogenous metabolic dysregulation in clinical toxicology.
Chen C; Fan Z; Xu H; Tan X; Zhu M
Biomed Chromatogr; 2019 Feb; 33(2):e4413. PubMed ID: 30357883
[TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.
Knippenberg S; Smolders J; Thewissen M; Peelen E; Tervaert JW; Hupperts R; Damoiseaux J
Mult Scler; 2011 Dec; 17(12):1418-23. PubMed ID: 21690147
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
